Federal Health Grants

The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. Candidates are encouraged to apply for support from this NINDS K01 any time between the second through fourth year of cumulative mentored postdoctoral research experience, and may be supported by this NINDS K01 within the first 6 years of cumulative postdoctoral research experience. Because the completion of a strong, well-planned, thorough career development plan, in addition to development of an impactful research project, is a critical aspect of this K01, applications are strongly encouraged early in the postdoctoral eligibility window. By the end of the proposed K01 award period, the candidate should be poised to begin an independent research career with a well-developed, impactful research project and the expertise required to become a leader in the field.This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

The National Institute on Drug Abuseintends to promote a new initiative by publishing a notice of funding opportunity (NOFO) to seek applications for research hubs to participate in Phase II of the Justice Community Overdose Innovation Network (JCOIN). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Fall 2025with an expected application due date in Winter 2025. Details of the planned NOFO are provided below.

This funding opportunity supports researchers in developing innovative resources and technologies to improve the reliability and applicability of animal models in biomedical research, with a focus on projects that address broad health issues and involve multiple NIH Institutes.

This funding opportunity supports organizations in Jordan that empower parents of children with disabilities by providing advocacy tools, educational resources, and promoting social inclusion.

This funding opportunity supports research on how diet and lipid metabolism influence tumor growth and progression, targeting higher education institutions, nonprofits, and certain for-profit organizations with expertise in nutrition science.

This funding opportunity provides financial support to various organizations to enhance Indonesia's public health systems and capacity through collaboration with the Ministry of Health, focusing on critical areas like surveillance, laboratory systems, and emergency response.

This grant provides funding for researchers to develop and validate innovative, safe, and noninvasive methods for real-time assessment of placenta development and function throughout pregnancy, ultimately aiming to improve maternal and fetal health outcomes.

This funding opportunity provides financial support to state and territorial governments to improve and expand essential services for victims of sexual assault, including crisis intervention, advocacy, and community-based support.

Reissue PAR-19-220.

This program provides funding to early-career researchers who have received specific NIDDK K awards, enabling them to conduct small-scale research projects that will help them transition to independent investigator roles.

This funding opportunity supports seven existing research institutions focused on improving global understanding and response to the HIV epidemic through collaborative epidemiological data analysis.

This grant provides funding for innovative research projects aimed at improving mental health services and access for underserved populations, focusing on non-clinical trial methodologies.

This funding opportunity supports early-career clinical scientists from diverse backgrounds in developing their research skills and addressing cancer health disparities through mentored research experiences in cancer-related fields.

This funding opportunity provides financial support to organizations working in Tanzania to improve HIV prevention and treatment services, strengthen local health systems, and promote health equity for people living with HIV.

This grant provides funding to support advanced students and postdoctoral researchers in neuroscience, helping them gain the skills needed to translate basic research into clinical applications for neurological diseases.

This funding opportunity supports research projects that evaluate and improve crisis response services for suicide prevention, targeting a wide range of eligible applicants including universities, nonprofits, and government entities.

This funding opportunity supports research projects that include clinical trials aimed at improving health outcomes, targeting a wide range of eligible applicants such as universities, nonprofits, and for-profit organizations.

This grant provides funding for short courses that aim to enhance research skills in using cognitive data to study aging and Alzheimer's disease across different countries, ultimately improving health outcomes and informing policies.

The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collaborating on a single set of integrated specific aims, culminating in data on optimal parameters for a future proposed clinical efficacy trial, as well as the development and validation of other critical knowledge and methods for interpretation of such a trial, such as clinical assessment of the engagement of an outcome-relevant target. Enhancing workforce and institutional capacity to conduct future rigorous, transdisciplinary research on chemically complex natural products must be built into the plans for research and for enhancing diverse perspectives. Achievement of the RM1 specific aims is expected to provide a strong foundation for a future highly informative clinical efficacy trial of the effects on resilience of a chemically complex natural product.This NOFO is one component of the Consortium Advancing Research on Botanicals and Other Natural Products (CARBON) Program. Other components of this Program include RFA-AT-24-008, Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01) and RFA-AT-24-007, Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24).

The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.